ArticleFrontiers in oncology2025

Tocilizumab improves the efficacy of anti-PD-1 in a patient with advanced gastroesophageal junction cancer: a case report.

Yushi Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.